8-K/A - Amneal Pharmaceuticals, Inc. (0001723128) (Filer)
Published . Updated .
Key takeaways
- 8-K/A - Amneal Pharmaceuticals filed an 8-K with the SEC on Oct 23 (a notice of a material company event).
- Exposed: AMRX
- Market reaction: AMRX +4.7% after three sessions
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K/A - Amneal Pharmaceuticals filed an 8-K with the SEC on Oct 23 (a notice of a material company event).
Directly affected
- AMRX Amneal Pharmaceuticals
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- LLY Eli Lilly and
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- JNJ Johnson & Johnson
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- PFE Pfizer
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- MRK Merck
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| AMRX | -4.91% | -0.83% | base | +3.36% | +5.25% | +3.83% | +4.74% |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| XBINo price data for this ticker | — | — | — | — | — | — | — |
| LLYNo price data for this ticker | — | — | — | — | — | — | — |
| JNJNo price data for this ticker | — | — | — | — | — | — | — |
| PFENo price data for this ticker | — | — | — | — | — | — | — |
| MRKNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-10-23 AccNo: 0001140361-26-040656 Size: 3 MB Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
How far Amneal Pharmaceuticals (AMRX) has moved since 23 Oct 2026
Since the first closing price after “8-K/A - Amneal Pharmaceuticals, Inc. (0001723128) (Filer),” Amneal Pharmaceuticals (AMRX) is +1.76%. The S&P 500 fund (SPY) is +0.58% over the same days, a +1.18% difference versus the market.
| Company | When | Move | Status |
|---|---|---|---|
| Amneal Pharmaceuticals (AMRX) | that day | +3.36% | final price |
| Amneal Pharmaceuticals (AMRX) | the next day | +5.25% | final price |
| Amneal Pharmaceuticals (AMRX) | two days later | +3.83% | final price |
| Amneal Pharmaceuticals (AMRX) | three days later | +4.74% | final price |
| Amneal Pharmaceuticals (AMRX) | three days earlier | -0.83% | final price |
| Amneal Pharmaceuticals (AMRX) | five days earlier | -4.91% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 49 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 16 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 23 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 28 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 49 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 63 days before publication. Filed 8 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 31 Jul 2026. That is 84 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 29 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 65 days before publication. Filed 9 Sep 2026. View the filing.
- Donald J Trump, an executive branch official, sold Merck (MRK), worth $250,001 - $500,000 on 31 Jul 2026. That is 84 days before publication. Filed 22 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K/A - Amneal Pharmaceuticals, Inc. (0001723128) (Filer)”
Companies mentioned with this story
- AMRX Amneal Pharmaceuticals
For “8-K/A - Amneal Pharmaceuticals, Inc. (0001723128) (Filer),” Amneal Pharmaceuticals (AMRX) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> AMRX
How “8-K/A - Amneal Pharmaceuticals, Inc. (0001723128) (Filer)” reaches Amneal Pharmaceuticals (AMRX)
Amneal Pharmaceuticals (AMRX) is the company in “8-K/A - Amneal Pharmaceuticals, Inc. (0001723128) (Filer),” the 23 Oct 2026 this story story.
What ties Amneal Pharmaceuticals (AMRX) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> AMRX
Dates and price levels for Amneal Pharmaceuticals (AMRX)
AMRX traded between 18.79 and 21.68 across 20 sessions. The latest close on file is 21.39.
What the saved facts support for Amneal Pharmaceuticals (AMRX)
14 out of 100
“8-K/A - Amneal Pharmaceuticals, Inc. (0001723128) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.